Literature DB >> 25054430

Differentiating drug-induced multichannel block on the electrocardiogram: randomized study of dofetilide, quinidine, ranolazine, and verapamil.

L Johannesen1, J Vicente2, J W Mason3, C Sanabria3, K Waite-Labott3, M Hong4, P Guo4, J Lin4, J S Sørensen5, L Galeotti6, J Florian5, M Ugander1, N Stockbridge7, D G Strauss1.   

Abstract

Block of the hERG potassium channel and prolongation of the QT interval are predictors of drug-induced torsade de pointes. However, drugs that block the hERG potassium channel may also block other channels that mitigate torsade risk. We hypothesized that the electrocardiogram can differentiate the effects of multichannel drug block by separate analysis of early repolarization (global J-Tpeak) and late repolarization (global Tpeak-Tend). In this prospective randomized controlled clinical trial, 22 subjects received a pure hERG potassium channel blocker (dofetilide) and three drugs that block hERG and either calcium or late sodium currents (quinidine, ranolazine, and verapamil). The results show that hERG potassium channel block equally prolongs early and late repolarization, whereas additional inward current block (calcium or late sodium) preferentially shortens early repolarization. Characterization of multichannel drug effects on human cardiac repolarization is possible and may improve the utility of the electrocardiogram in the assessment of drug-related cardiac electrophysiology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25054430     DOI: 10.1038/clpt.2014.155

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  61 in total

1.  The T-peak-T-end interval as a marker of repolarization abnormality: a comparison with the QT interval for five different drugs.

Authors:  Tanveer A Bhuiyan; Claus Graff; Jørgen K Kanters; Jimmi Nielsen; Jacob Melgaard; Jørgen Matz; Egon Toft; Johannes J Struijk
Journal:  Clin Drug Investig       Date:  2015-11       Impact factor: 2.859

2.  Common Genetic Variant Risk Score Is Associated With Drug-Induced QT Prolongation and Torsade de Pointes Risk: A Pilot Study.

Authors:  David G Strauss; Jose Vicente; Lars Johannesen; Ksenia Blinova; Jay W Mason; Peter Weeke; Elijah R Behr; Dan M Roden; Ray Woosley; Gulum Kosova; Michael A Rosenberg; Christopher Newton-Cheh
Journal:  Circulation       Date:  2017-02-17       Impact factor: 29.690

3.  FutureTox III: Bridges for Translation.

Authors:  Daland R Juberg; Thomas B Knudsen; Miriam Sander; Nancy B Beck; Elaine M Faustman; Donna L Mendrick; John R Fowle; Thomas Hartung; Raymond R Tice; Emmanuel Lemazurier; Richard A Becker; Suzanne Compton Fitzpatrick; George P Daston; Alison Harrill; Ronald N Hines; Douglas A Keller; John C Lipscomb; David Watson; Tina Bahadori; Kevin M Crofton
Journal:  Toxicol Sci       Date:  2016-10-25       Impact factor: 4.849

4.  Minimal T-wave representation and its use in the assessment of drug arrhythmogenicity.

Authors:  Saeed Shakibfar; Claus Graff; Jørgen K Kanters; Jimmi Nielsen; Samuel Schmidt; Johannes J Struijk
Journal:  Ann Noninvasive Electrocardiol       Date:  2016-10-27       Impact factor: 1.468

5.  Changes in global electrical heterogeneity associated with dofetilide, quinidine, ranolazine, and verapamil.

Authors:  Hans Friedrich Stabenau; Changyu Shen; Larisa G Tereshchenko; Jonathan W Waks
Journal:  Heart Rhythm       Date:  2019-09-17       Impact factor: 6.343

6.  Human ex-vivo action potential model for pro-arrhythmia risk assessment.

Authors:  Guy Page; Phachareeya Ratchada; Yannick Miron; Guido Steiner; Andre Ghetti; Paul E Miller; Jack A Reynolds; Ken Wang; Andrea Greiter-Wilke; Liudmila Polonchuk; Martin Traebert; Gary A Gintant; Najah Abi-Gerges
Journal:  J Pharmacol Toxicol Methods       Date:  2016-05-25       Impact factor: 1.950

Review 7.  Scientific white paper on concentration-QTc modeling.

Authors:  Christine Garnett; Peter L Bonate; Qianyu Dang; Georg Ferber; Dalong Huang; Jiang Liu; Devan Mehrotra; Steve Riley; Philip Sager; Christoffer Tornoe; Yaning Wang
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-12-05       Impact factor: 2.745

8.  Is myocardial repolarization duration associated with repolarization heterogeneity?

Authors:  Keith A Marill; Pat Dorsey; Anthony Holmes; Ketaki Muthal; Emily S Miller; Joel Xue
Journal:  Ann Noninvasive Electrocardiol       Date:  2017-12-02       Impact factor: 1.468

9.  Predicting critical drug concentrations and torsadogenic risk using a multiscale exposure-response simulator.

Authors:  Francisco Sahli Costabal; Jiang Yao; Anna Sher; Ellen Kuhl
Journal:  Prog Biophys Mol Biol       Date:  2018-10-26       Impact factor: 3.667

10.  Late sodium current block for drug-induced long QT syndrome: Results from a prospective clinical trial.

Authors:  L Johannesen; J Vicente; J W Mason; C Erato; C Sanabria; K Waite-Labott; M Hong; J Lin; P Guo; A Mutlib; J Wang; W J Crumb; K Blinova; D Chan; J Stohlman; J Florian; M Ugander; N Stockbridge; D G Strauss
Journal:  Clin Pharmacol Ther       Date:  2015-11-28       Impact factor: 6.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.